From Yahoo Finance: 2025-04-01 12:10:00

Argus has lowered Illumina’s price target to $100 from $170 but maintains a Buy rating, citing geopolitical tensions and slowing product sales. The firm believes Illumina is improving with margin growth, new products, and strong earnings guidance for 2025. The discounted price presents a buying opportunity, according to Argus.

Read more: Argus cuts Illumina target, sees buying opportunity